Home » Ambion Announces Continued Alliance With Wyeth
Ambion Announces Continued Alliance With Wyeth
Ambion Diagnostics, a division of Ambion, has entered into a new agreement with Wyeth Pharmaceuticals to continue its alliance in the development and supply of cGMP-grade RNA that will be incorporated as a component in Wyeth's innovative vaccine program. Ambion Diagnostics will manufacture RNA transcripts according to QSR guidelines and will supply the material at a scale sufficient to meet Wyeth's requirements for Phase I/II clinical trials.
Austin dBusiness News (http://austin.dbusinessnews.com/shownews.php?newsid=13978&type_news=latest)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May